300244 迪安診斷
按盤價 
12.390 -0.860 (-6.491%)
12.390 -0.860 (-6.491%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 9,258,111 | -10.05% | 13,408,320 | 20,282,469 | 13,082,613 | 10,649,162 | |
| 減：營業總成本 | 8,491,254 | -5.42% | 12,243,282 | 16,603,821 | 11,084,409 | 8,862,648 | |
| 其中:營業成本 | 6,661,093 | -3.67% | 9,213,383 | 12,745,811 | 8,076,949 | 6,578,706 | |
| 財務費用 | 151,791 | -10.43% | 220,608 | 298,236 | 217,479 | 195,875 | |
| 資產減值損失 | 767 | -199.27% | (16,738) | (624,025) | (272,189) | (475,247) | |
| 公允價值變動收益 | (15,805) | -162.53% | (727) | (56,236) | 83,354 | (2,586) | |
| 投資收益 | 9,184 | 1,353.03% | (17,596) | 48,787 | 55,338 | 73,148 | |
| 其中：對聯營企業和合營企業的投資收益 | 12,637 | -10,913.30% | (6,722) | 26,763 | 39,785 | 20,783 | |
| 營業利潤 | 435,847 | -57.78% | 842,183 | 2,822,609 | 1,837,935 | 1,320,311 | |
| 利潤總額 | 424,172 | -58.47% | 798,326 | 2,543,562 | 1,790,997 | 1,317,395 | |
| 減：所得稅費用 | 121,488 | -47.18% | 216,735 | 681,092 | 307,396 | 247,461 | |
| 淨利潤 | 302,684 | -61.75% | 581,591 | 1,862,470 | 1,483,601 | 1,069,934 | |
| 減：非控股權益 | 171,827 | -34.05% | 274,130 | 428,279 | 320,717 | 267,002 | |
| 股東淨利潤 | 130,857 | -75.35% | 307,461 | 1,434,191 | 1,162,884 | 802,933 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.212 | -74.99% | 0.492 | 2.302 | 1.874 | 1.294 | |
| 每股派息 (元) * | 0.650 | -- | 0.060 | 0.200 | 0.135 | 0.130 | |
| 每股淨資產 (元) * | 11.292 | -9.78% | 12.069 | 11.881 | 9.416 | 7.572 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 22/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
